A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Cancer Lung Cancer Non-Small Cell Lung Cancer (NSCLC)
For the latest version of this information please go to www.forpatients.roche.com